EUVIMEDEUVIMED entdecken
Crossref

Exploration and Practice of Introducing the Pharmaceutical Care Network Europe Classification System to Psychiatric Drugs

Menglan Shi iD, Yan Ma, Hong Li, Fangjie Li, Shujuan Shen

Journal of Pharmacy Practice · 2025

DOI: 10.1177/08971900241273200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy Practice, 2025. Verfasst von Menglan Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shanghai Mental Health Center, Shanghai, PR China. Hauptthemen laut MEDLINE: Psychotropic Drugs, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 28 Literaturangaben. Gefördert von: The foundation of Shanghai mental health center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research aims to summarize and discuss issues related to psychiatric drugs by using the classification system of the Pharmaceutical Care Network Europe (PCNE) and to provide a reference for the development and direction of clinical pharmacists’ work in the future. Psychiatric patients who were hospitalized in our hospital from Janurary 2023 to December 2023 were enrolled. Drug-related problems (DRPs) were evaluated using the PCNE classification system (version 9.0). The types, causes, intervention plans, acceptance of intervention plans, and statuses of DRPs were analyzed. A total of 362 patients were included, covering 405 DRP cases, with an average DRP of 1.12 for each patient. All 405 DRP cases underwent interventions, with a success rate of 83.46%. The main categories of related drugs were psychotropic drugs (70.37%), anti-infective drugs (8.89%), and cardiovascular system drugs (5.19%). The main DRPs were possible adverse drug events (21.24%), poor treatment effects (69.14%), and unnecessary medication treatment (9.63%). The main causes of DRPs were inappropriate drug selection (18.52%), inappropriate combinations of drugs (16.05%), and excessive drug dosage (13.58%). The PCNE classification system helps clinical pharmacists improve their ability to identify and solve DRPs faced by psychiatric departments, improve pharmaceutical care efficiency, and ensure rational drug use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Psychotropic DrugsDrug-Related Side Effects and Adverse ReactionsHumansMaleEuropeFemaleMiddle AgedAdultPharmacistsMental DisordersPharmacy Service, HospitalAgedPharmaceutical Services

Stichwörter der Autor:innen

clinical pharmacistdrug-related problempharmaceutical care network Europe classification systempsychiatric departmentrational drug use

Substanzen

Psychotropic Drugs

Autor:innen und Institutionen

  • Department of Pharmacy, Shanghai Mental Health Center, Shanghai, PR China.

ORCID-Profile: Menglan Shi

Förderung

  • The foundation of Shanghai mental health center

Zitieren

APA

Shi, M., Ma, Y., Li, H., Li, F., & Shen, S. (2025). Exploration and Practice of Introducing the Pharmaceutical Care Network Europe Classification System to Psychiatric Drugs. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900241273200

Vancouver

Shi M, Ma Y, Li H, Li F, Shen S. Exploration and Practice of Introducing the Pharmaceutical Care Network Europe Classification System to Psychiatric Drugs. Journal of Pharmacy Practice. 2025. doi:10.1177/08971900241273200

BibTeX
@article{Shi2025,
  author = {Shi, Menglan and Ma, Yan and Li, Hong and Li, Fangjie and Shen, Shujuan},
  title = {Exploration and Practice of Introducing the Pharmaceutical Care Network Europe Classification System to Psychiatric Drugs},
  journal = {Journal of Pharmacy Practice},
  year = {2025},
  doi = {10.1177/08971900241273200}
}
Kostenlos starten →